@BoussageonR @DocTotoscope OK j'etais pas allé chercher aussi loin! Donc pour cause non cardiaque, atorva 80. A noter que simva 40 semble faire aussi bien https://t.co/7wNfWByJTL
@mackdm @malcolmken @Gladwell @DoctorTro @BrianLenzkes @holmanm @sciencecohen Depends who you ask. Here's from one giant often cited study, where they seem to say technically they prevent stroke but not in a meaningful way. They don't improve outcomes but
SR & network MA (published data only) showing #Statins reduce the risk of recurrent #ischemic strokes & other cardiovascular events in patients with a previous #stroke or #TIA https://t.co/wanS8LJjmp
虚血性脳卒中患者に対するスタチンの二次予防としての使用は、全原因死亡や脳卒中のリスクに影響しないようだった(虚血性脳卒中の再発、心血管イベントのリスク減少と関連した)。 https://t.co/afo4jCTgKb
RT @Echoraljpangio: https://t.co/hr2l6MBtqU Comparison of statins for secondary prevention in patients with ischemic stroke or transient is…
RT @Echoraljpangio: Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systema…
https://t.co/hr2l6MBtqU Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis @alebura @GMahe_ @BozonGuillaume @AtulPathak31 @FZores @ClubVasculaire #VASC
Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis https://t.co/hr2l6MBtqU #
RT @BMCMedicine: Comparison of #statins for secondary prevention in patients with ischemic #stroke or transient ischemic attack: a systemat…
RT @BMCMedicine: Comparison of #statins for secondary prevention in patients with ischemic #stroke or transient ischemic attack: a systemat…
Comparison of #statins for secondary prevention in patients with ischemic #stroke or transient ischemic attack: a systematic #review and network meta-analysis https://t.co/V3p6amYgnR https://t.co/QnfxcCyo31